Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Preliminary results of radiotherapy for primary intraocular non-Hodgkin lymphoma.

Mikami R, Nakayama H, Goto H, Kimura K, Usui Y, Nogi S, Tajima Y, Okubo M, Kanesaka N, Sugahara S, Tokuuye K.

Leuk Lymphoma. 2013 Oct;54(10):2181-4. doi: 10.3109/10428194.2013.769216. Epub 2013 Feb 21.

PMID:
23343177
2.

Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.

Hormigo A, Abrey L, Heinemann MH, DeAngelis LM.

Br J Haematol. 2004 Jul;126(2):202-8.

PMID:
15238140
3.

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Grimm SA, Pulido JS, Jahnke K, Schiff D, Hall AJ, Shenkier TN, Siegal T, Doolittle ND, Batchelor T, Herrlinger U, Neuwelt EA, Laperriere N, Chamberlain MC, Blay JY, Ferreri AJ, Omuro AM, Thiel E, Abrey LE.

Ann Oncol. 2007 Nov;18(11):1851-5. Epub 2007 Sep 5.

PMID:
17804469
4.

Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.

Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, Harris NL, Ferry JA.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1382-91.

PMID:
14630277
5.

Curative radiotherapy for primary orbital lymphoma.

Bhatia S, Paulino AC, Buatti JM, Mayr NA, Wen BC.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):818-23. Review.

PMID:
12377334
6.

Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy.

Berenbom A, Davila RM, Lin HS, Harbour JW.

Eye (Lond). 2007 Sep;21(9):1198-201. Epub 2006 May 26.

PMID:
16732210
7.

Primary central nervous system lymphoma: age and performance status are more important than treatment modality.

Corry J, Smith JG, Wirth A, Quong G, Liew KH.

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):615-20.

PMID:
9635710
8.

Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.

Hashimoto N, Sasaki R, Nishimura H, Yoshida K, Miyawaki D, Nakayama M, Uehara K, Okamoto Y, Ejima Y, Azumi A, Matsui T, Sugimura K.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1509-14. doi: 10.1016/j.ijrobp.2011.04.052. Epub 2011 Jun 12.

PMID:
21664061
9.

Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma.

Ishikawa H, Hasegawa M, Tamaki Y, Hayakawa K, Akimoto T, Sakurai H, Mitsuhashi N, Niibe H, Tamura M, Nakano T.

Jpn J Clin Oncol. 2003 Sep;33(9):443-9.

PMID:
14594937
10.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
11.

High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.

Alvarnas JC, Negrin RS, Horning SJ, Hu WW, Long GD, Schriber JR, Stockerl-Goldstein K, Tierney K, Wong R, Blume KG, Chao NJ.

Biol Blood Marrow Transplant. 2000;6(3A):352-8.

PMID:
10905773
12.

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.

Martinet S, Ozsahin M, Belkacémi Y, Landmann C, Poortmans P, Oehlere C, Scandolaro L, Krengli M, Maingon P, Miralbell R, Studer G, Chauvet B, Marnitz S, Zouhair A, Mirimanoff RO.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):892-8.

PMID:
12605966
13.

[Radiotherapy of primary intraocular lymphoma associated with primary central nervous system lymphoma].

Tropinskaya OF, Vetlova ER, Serova NK, Golanov AV, Fil'chenkova NA.

Zh Vopr Neirokhir Im N N Burdenko. 2016;80(3):74-81. doi: 10.17116/neiro201680374-81. Russian.

14.

Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.

Wong WW, Schild SE, Halyard MY, Schomberg PJ.

J Surg Oncol. 2002 May;80(1):19-25; discussion 26. Review.

PMID:
11967901
15.

Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment.

Minehan KJ, Martenson JA Jr, Garrity JA, Kurtin PJ, Banks PM, Chen MG, Earle JD.

Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):791-6.

PMID:
2004956
16.

Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.

Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):501-8.

PMID:
15145169
17.

Prognosis of primary central nervous system lymphoma treated with radiotherapy alone.

Taguchi S, Hamamoto Y, Fujii T, Ochi T, Harada H, Ohnishi T, Mochizuki T.

Jpn J Radiol. 2012 Dec;30(10):806-10. doi: 10.1007/s11604-012-0124-1. Epub 2012 Sep 11.

PMID:
22961611
18.

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.

Pelloski CE, Wilder RB, Ha CS, Hess MA, Cabanillas FF, Cox JD.

Radiother Oncol. 2001 May;59(2):145-51.

PMID:
11325442
19.

Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.

Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD.

Eye (Lond). 2003 May;17(4):513-21.

PMID:
12802353
20.

Radiotherapy for localized relapse in patients with non-Hodgkin's lymphoma: a preliminary report.

Nakamura K, Kunitake N, Kimura M, Shioyama Y, Terashima H, Masuda K.

Radiat Med. 2000 Jul-Aug;18(4):245-8.

PMID:
11247000

Supplemental Content

Support Center